{"DataElement":{"publicId":"6782231","version":"1","preferredName":"Invasive Ductal Breast Carcinoma Histologic Classification Subtype Type","preferredDefinition":"The histologic subtype for the most common type of invasive breast carcinoma.","longName":"IDC_HIST_SUBTP_TP","context":"MCL","contextVersion":"1","DataElementConcept":{"publicId":"6781180","version":"1","preferredName":"Invasive Ductal Breast Carcinoma Histologic Classification Subtype","preferredDefinition":"The most common type of invasive breast carcinoma, accounting for approximately 70% of breast carcinomas.  The gross appearance is usually typical with an irregular stellate outline.  Microscopically, randomly arranged epithelial elements are seen.  When large sheets of malignant cells are present, necrosis may be seen.  With adequate tissue sampling, in situ carcinoma can be demonstrated in association with the infiltrating carcinoma.  The in situ component is nearly always ductal but occasionally may be lobular or both._Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics._A group forming a type within a larger type.","longName":"6781178v1.0:6771071v1.0","context":"MCL","contextVersion":"1","ObjectClass":{"publicId":"6781178","version":"1","preferredName":"Invasive Ductal Carcinoma, Not Otherwise Specified","preferredDefinition":"The most common type of invasive breast carcinoma, accounting for approximately 70% of breast carcinomas.  The gross appearance is usually typical with an irregular stellate outline.  Microscopically, randomly arranged epithelial elements are seen.  When large sheets of malignant cells are present, necrosis may be seen.  With adequate tissue sampling, in situ carcinoma can be demonstrated in association with the infiltrating carcinoma.  The in situ component is nearly always ductal but occasionally may be lobular or both.","longName":"C4194","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Carcinoma of No Special Type","conceptCode":"C4194","definition":"A term that refers to a large and heterogeneous group of invasive breast carcinomas that cannot be classified morphologically as any of the special histological types. (WHO 2019)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B494233-CC0A-0F5B-E053-F662850AF724","latestVersionIndicator":"Yes","beginDate":"2019-06-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-14","modifiedBy":"ONEDATA","dateModified":"2019-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6771071","version":"1","preferredName":"Histologic Classification Subtype","preferredDefinition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.:A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.:A group forming a type within a larger type.","longName":"C25526:C25161:C25696","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Subtype","conceptCode":"C25696","definition":"A group forming a type within a larger type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A1AE139-F912-798E-E053-F662850A3BB5","latestVersionIndicator":"Yes","beginDate":"2019-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-30","modifiedBy":"ONEDATA","dateModified":"2019-05-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B494233-CC18-0F5B-E053-F662850AF724","latestVersionIndicator":"Yes","beginDate":"2019-06-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-14","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeDescription":"3/8/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  6-14-19 tt created for Breast initial diagnosis and surgical therapy modules.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6782228","version":"1","preferredName":"Invasive Ductal Breast Carcinoma Type","preferredDefinition":"The most common type of invasive breast carcinoma, accounting for approximately 70% of breast carcinomas.  The gross appearance is usually typical with an irregular stellate outline.  Microscopically, randomly arranged epithelial elements are seen.  When large sheets of malignant cells are present, necrosis may be seen.  With adequate tissue sampling, in situ carcinoma can be demonstrated in association with the infiltrating carcinoma.  The in situ component is nearly always ductal but occasionally may be lobular or both._Something distinguishable as an identifiable class based on common qualities.","longName":"6782228v1.0","context":"MCL","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Data not available","valueDescription":"Source Data Not Available","ValueMeaning":{"publicId":"4842575","version":"1","preferredName":"Source Data Not Available","longName":"4842575","preferredDefinition":"Data from an original source is not present, accessible or ready for use or service.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Source Data Not Available","conceptCode":"C67329","definition":"Data from an original source is not present, accessible or ready for use or service.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"173BF844-9709-E098-E050-BB89AD431F3E","latestVersionIndicator":"Yes","beginDate":"2015-05-29","endDate":null,"createdBy":"LEEW","dateCreated":"2015-05-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8B4B4921-908D-4044-E053-F662850ADEE5","beginDate":"2019-06-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-14","modifiedBy":"ONEDATA","dateModified":"2019-06-14","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"5682944","version":"1","preferredName":"Unknown","longName":"5682944","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B0E12-9AE5-79DC-E053-F662850A0B75","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"GDEEN","dateModified":"2023-12-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8B4B4921-9097-4044-E053-F662850ADEE5","beginDate":"2019-06-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-14","modifiedBy":"ONEDATA","dateModified":"2019-06-14","deletedIndicator":"No"},{"value":"Other carcinoma, specify in free text field","valueDescription":"Specify Other","ValueMeaning":{"publicId":"6782229","version":"1","preferredName":"Specify Other","longName":"6782229","preferredDefinition":"A directive to indicate a response not listed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify Other","conceptCode":"C157106","definition":"A directive to indicate a response not listed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B4B4921-90A3-4044-E053-F662850ADEE5","latestVersionIndicator":"Yes","beginDate":"2019-06-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-14","modifiedBy":"TSESU","dateModified":"2022-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8B4B4921-90BB-4044-E053-F662850ADEE5","beginDate":"2019-06-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-14","modifiedBy":"ONEDATA","dateModified":"2019-06-14","deletedIndicator":"No"},{"value":"Invasive carcinoma, type cannot be determined","valueDescription":"Invasive Breast Carcinoma Type Indeterminate","ValueMeaning":{"publicId":"6782230","version":"1","preferredName":"Invasive Breast Carcinoma Type Indeterminate","longName":"6782230","preferredDefinition":"A carcinoma that infiltrates the breast parenchyma.  The vast majority are adenocarcinomas arising from the terminal ductal lobular unit (TDLU).  Often, the invasive adenocarcinoma co-exists with ductal or lobular carcinoma in situ.  It is the most common carcinoma affecting women.: Something distinguishable as an identifiable class based on common qualities.: Cannot distinguish between two or more possible values in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Carcinoma","conceptCode":"C9245","definition":"A carcinoma that infiltrates the breast parenchyma.  The vast majority are adenocarcinomas arising from the terminal ductal lobular unit (TDLU).  Often, the invasive adenocarcinoma co-exists with ductal or lobular carcinoma in situ.  It is the most common carcinoma affecting women.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indeterminate","conceptCode":"C48658","definition":"Cannot distinguish between two or more possible values in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B4B4921-90CA-4044-E053-F662850ADEE5","latestVersionIndicator":"Yes","beginDate":"2019-06-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-14","modifiedBy":"ONEDATA","dateModified":"2019-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8B4B4921-90E3-4044-E053-F662850ADEE5","beginDate":"2019-06-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-14","modifiedBy":"ONEDATA","dateModified":"2019-06-14","deletedIndicator":"No"},{"value":"Invasive cribriform carcinoma","valueDescription":"Invasive Cribriform Breast Carcinoma","ValueMeaning":{"publicId":"2581150","version":"1","preferredName":"Invasive Cribriform Breast Carcinoma","longName":"2581150","preferredDefinition":"An invasive adenocarcinoma of the breast with a favorable clinical outcome, characterized by the presence of a sieve-like or cribriform infiltrating pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Cribriform Carcinoma","conceptCode":"C5142","definition":"An invasive adenocarcinoma of the breast with a favorable clinical outcome, characterized by the presence of a sieve-like or cribriform infiltrating pattern.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A0B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"DWARZEL","dateModified":"2006-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8B4B4921-90ED-4044-E053-F662850ADEE5","beginDate":"2019-06-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-14","modifiedBy":"ONEDATA","dateModified":"2019-06-14","deletedIndicator":"No"},{"value":"Invasive tubular carcinoma","valueDescription":"Tubular Breast Carcinoma","ValueMeaning":{"publicId":"3669460","version":"1","preferredName":"Tubular Breast Carcinoma","longName":"3669460","preferredDefinition":"An invasive adenocarcinoma of the breast with a favorable prognosis. It is composed of tubular structures lined by a single layer of epithelium.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Tubular Carcinoma","conceptCode":"C9135","definition":"An invasive adenocarcinoma of the breast with a favorable prognosis.  It is composed of tubular structures lined by a single layer of epithelium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-789A-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8B4B4921-9101-4044-E053-F662850ADEE5","beginDate":"2019-06-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-14","modifiedBy":"ONEDATA","dateModified":"2019-06-14","deletedIndicator":"No"},{"value":"Invasive micropapillary carcinoma","valueDescription":"Invasive Micropapillary Breast Carcinoma","ValueMeaning":{"publicId":"3248497","version":"1","preferredName":"Invasive Micropapillary Breast Carcinoma","longName":"3248497","preferredDefinition":"An invasive breast carcinoma characterized by the presence of clusters of malignant cells located within artifactual clear stromal spaces that resemble vascular spaces.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Micropapillary Carcinoma","conceptCode":"C36084","definition":"An invasive breast carcinoma characterized by the presence of clusters of malignant cells located within artifactual clear stromal spaces that resemble vascular spaces.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6B8531E-17EB-F891-E040-BB89AD4324F8","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"COOPERM","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8B4B4921-910B-4044-E053-F662850ADEE5","beginDate":"2019-06-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-14","modifiedBy":"ONEDATA","dateModified":"2019-06-14","deletedIndicator":"No"},{"value":"Invasive papillary carcinoma","valueDescription":"Invasive Papillary Breast Carcinoma","ValueMeaning":{"publicId":"5914244","version":"1","preferredName":"Invasive Papillary Breast Carcinoma","longName":"5914244","preferredDefinition":"A ductal breast carcinoma which invades the breast parenchyma.  It is characterized by the formation of papillary structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Papillary Carcinoma","conceptCode":"C36085","definition":"An invasive breast carcinoma characterized by the presence of papillary structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54AE7EF7-3E0E-21B7-E053-F662850AEBEC","latestVersionIndicator":"Yes","beginDate":"2017-07-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8B4B4921-9115-4044-E053-F662850ADEE5","beginDate":"2019-06-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-14","modifiedBy":"ONEDATA","dateModified":"2019-06-14","deletedIndicator":"No"},{"value":"Medullary carcinoma","valueDescription":"Medullary Breast Carcinoma","ValueMeaning":{"publicId":"3669459","version":"1","preferredName":"Medullary Breast Carcinoma","longName":"3669459","preferredDefinition":"An infiltrating breast carcinoma distinguished by its allegedly good prognosis. Medullary breast carcinoma is uncommon, accounting for fewer than 1% of all infiltrating breast carcinomas. Grossly, this is a well circumscribed tumor, with soft cut surface ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Medullary Carcinoma","conceptCode":"C9119","definition":"An infiltrating breast carcinoma with a relatively favorable prognosis.  It is an uncommon carcinoma, accounting for less than 1% of all infiltrating breast carcinomas.  It is well circumscribed, with soft cut surface and often of considerable size.  Microscopically, the predominant growth pattern is syncytial with broad anastomosing bands or sheets of malignant cells.  The malignant cells are round with abundant cytoplasm and vesicular nuclei.  The sheets of malignant cells are associated with a marked lymphoplasmacytic infiltrate.  Glandular or tubular structures are absent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-7862-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8B4B4921-9120-4044-E053-F662850ADEE5","beginDate":"2019-06-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-14","modifiedBy":"ONEDATA","dateModified":"2019-06-14","deletedIndicator":"No"},{"value":"Mucinous carcinoma","valueDescription":"Mucinous Breast Carcinoma","ValueMeaning":{"publicId":"3243624","version":"1","preferredName":"Mucinous Breast Carcinoma","longName":"3243624","preferredDefinition":"An invasive adenocarcinoma of the breast characterized by the presence of islands of small and uniform cells, surrounded by large amounts of mucin. Pure mucinous breast carcinomas have generally a favorable prognosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Mucinous Carcinoma","conceptCode":"C9131","definition":"An invasive adenocarcinoma of the breast characterized by the presence of islands of small and uniform cells, surrounded by large amounts of mucin.  Pure mucinous breast carcinomas generally have a favorable prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A55DCBB1-7268-F00A-E040-BB89AD431D27","latestVersionIndicator":"Yes","beginDate":"2011-06-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-06-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8B4B4921-912A-4044-E053-F662850ADEE5","beginDate":"2019-06-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-14","modifiedBy":"ONEDATA","dateModified":"2019-06-14","deletedIndicator":"No"},{"value":"Tubulolobular carcinoma","valueDescription":"Invasive Lobular Breast Carcinoma, Tubulolobular Variant","ValueMeaning":{"publicId":"3248498","version":"1","preferredName":"Invasive Lobular Breast Carcinoma, Tubulolobular Variant","longName":"3248498","preferredDefinition":"An invasive lobular carcinoma of the breast, characterized by the presence of neoplastic cells forming small tubular structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Lobular Carcinoma, Tubulolobular Variant","conceptCode":"C97053","definition":"An invasive lobular carcinoma of the breast, characterized by the presence of neoplastic cells forming small tubular structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6B8531E-180E-F891-E040-BB89AD4324F8","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"COOPERM","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8B4B4921-913E-4044-E053-F662850ADEE5","beginDate":"2019-06-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-14","modifiedBy":"ONEDATA","dateModified":"2019-06-14","deletedIndicator":"No"},{"value":"Classical type","valueDescription":"Invasive Ductal Breast Carcinoma Classic Histology","ValueMeaning":{"publicId":"6782232","version":"1","preferredName":"Invasive Ductal Breast Carcinoma Classic Histology","longName":"6782232","preferredDefinition":"Marked by a tendency to spread, especially into healthy surrounding tissue.: A breast carcinoma arising from the ducts.  While ductal carcinomas can arise at other sites, this term is universally used to refer to carcinomas of the breast.  Ductal carcinomas account for about two thirds of all breast cancers.  Two types of ductal carcinomas have been described: ductal carcinoma in situ (DCIS) and invasive ductal carcinoma.  The latter often spreads to the axillary lymph nodes and other anatomic sites.  The two forms of ductal carcinoma often coexist.: A term that refers to the histologic image of a lesion which carries all the characteristic morphologic findings which are necessary to define this lesion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive","conceptCode":"C14159","definition":"Marked by a tendency to spread, especially into healthy surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Breast Ductal Carcinoma","conceptCode":"C4017","definition":"A breast carcinoma arising from the ducts.  While ductal carcinomas can arise at other sites, this term is universally used to refer to carcinomas of the breast. Ductal carcinomas account for about two thirds of all breast cancers. Two types of ductal carcinomas have been described: ductal carcinoma in situ (DCIS) and invasive breast carcinoma of no special type. The latter often spreads to the axillary lymph nodes and other anatomic sites. The two forms of ductal carcinoma often coexist.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classic Histology","conceptCode":"C129470","definition":"A term that refers to the histologic image of a lesion which carries all the characteristic morphologic findings which are necessary to define this lesion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B4AEFB1-0DF4-3E3B-E053-F662850A5DD6","latestVersionIndicator":"Yes","beginDate":"2019-06-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-14","modifiedBy":"ONEDATA","dateModified":"2019-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8B4AEFB1-0E0D-3E3B-E053-F662850A5DD6","beginDate":"2019-06-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-14","modifiedBy":"ONEDATA","dateModified":"2019-06-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6782227","version":"1","preferredName":"Invasive Ductal Carcinoma, Not Otherwise Specified Type","preferredDefinition":"The most common type of invasive breast carcinoma, accounting for approximately 70% of breast carcinomas.  The gross appearance is usually typical with an irregular stellate outline.  Microscopically, randomly arranged epithelial elements are seen.  When large sheets of malignant cells are present, necrosis may be seen.  With adequate tissue sampling, in situ carcinoma can be demonstrated in association with the infiltrating carcinoma.  The in situ component is nearly always ductal but occasionally may be lobular or both.:Something distinguishable as an identifiable class based on common qualities.","longName":"C4194:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Carcinoma of No Special Type","conceptCode":"C4194","definition":"A term that refers to a large and heterogeneous group of invasive breast carcinomas that cannot be classified morphologically as any of the special histological types. (WHO 2019)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B4B4921-9064-4044-E053-F662850ADEE5","latestVersionIndicator":"Yes","beginDate":"2019-06-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-14","modifiedBy":"ONEDATA","dateModified":"2019-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B4B4921-9075-4044-E053-F662850ADEE5","latestVersionIndicator":"Yes","beginDate":"2019-06-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-14","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeDescription":"3/8/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  6-14-19 tt created for Breast initial diagnosis and surgical therapy modules.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5506112","version":"1","longName":"Breast","context":"MCL","ClassificationSchemeItems":[{"publicId":"6643184","version":"1","longName":"Surgical Therapy","context":"MCL"},{"publicId":"6643181","version":"1","longName":"Initial Diagnosis","context":"MCL"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Invasive ductal carcinoma type","type":"Preferred Question Text","description":"Invasive ductal carcinoma type","url":null,"context":"MCL"}],"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B4B6666-ADAD-355C-E053-F662850ABC74","latestVersionIndicator":"Yes","beginDate":"2019-06-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-14","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeDescription":"3/8/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  6-14-19 tt created for Breast initial diagnosis and surgical therapy modules.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}